Vertex Pharmaceuticals: 6th week, earnings just ahead
Vertex Pharmaceuticals stock: -0.1% this week, earnings due August 3
Vertex Pharmaceuticals: 6th week, earnings just ahead
Our view last week
Vertex Pharmaceuticals shares bounce 3% off the 50-day moving average, in the 470 area, after a touch near 465, but the week still closes down 1.7% and the buy signal, now in its fifth week, is losing steam: strength drops to 66 out of 100. Price closed below the first stop level (SL1) flagged in last week's card (area 477.4): for anyone following that level the trade is closed.
This week's summary
Vertex Pharmaceuticals shares close the week almost flat (-0.1%), with a sequence of three lower highs sliding from the 534 area to the 494 area: our weekly technical analysis reads this as a pause, not yet a reversal. The buy signal is now in its 6th week, and the stop has already moved up to breakeven on entry, locking the gain in. Worth watching: earnings land this very week, on August 3, and could move the stock either way.
IQS Phase
61
ordinary
Signal Strength
66
medium
Sizing
STANDARD
Ranking
#27 / 120
US stocks in progress
Trade P&L %
+5.64%
from signal to date, no stop loss
Rank position
ranks 27th among the 120 Longs already running for US stocks in our ranking, with a signal strength of 66 out of 100.
Sector context
SectorHealth Care
Benchmark ETFXLV
Sector regimein positive regime
Performanceweekly -0.01% · monthly +1.89%
VRTX belongs to the health care sector (reference ETF XLV). The sector is classified in positive regime according to our weekly reading.
restricted Platinum content